Status:
COMPLETED
Pilot Study on the Usefulness of 3,4-diaminopyridine in the Treatment of Botulism
Lead Sponsor:
Centre Hospitalier Universitaire, Amiens
Conditions:
Botulism
Eligibility:
All Genders
18+ years
Phase:
PHASE2
PHASE3
Brief Summary
Main objectives: Evaluate the effectiveness of an administration of 3,4-diaminopyridine (FIRDAPSE ®) in severe botulinic poisoning in measuring the effect on electrophysiological and respiratory para...
Detailed Description
Main objectives: Evaluate the effectiveness of an administration of 3,4-diaminopyridine (FIRDAPSE ®) in severe botulinic poisoning in measuring the effect on electrophysiological and respiratory para...
Eligibility Criteria
Inclusion
- botulism
- ventilation
Exclusion
- renal failure
- cardiac failure
- pregnancy
- under age 18
- hepatic failure
Key Trial Info
Start Date :
September 1 2011
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 1 2012
Estimated Enrollment :
3 Patients enrolled
Trial Details
Trial ID
NCT01441557
Start Date
September 1 2011
End Date
March 1 2012
Last Update
September 19 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
CHU
Amiens, France, 80000